Impact of Antimicrobial Stewardship Programs in the Global Setting
PEARL
Partnership to Enhance Antimicrobial Use in Resource-Limited Settings (PEARL): An Assessment of Need and Feasibility of Antimicrobial Stewardship Programs
1 other identifier
observational
3,115
1 country
1
Brief Summary
Antimicrobial resistance is one of the greatest threats to human health, and is driven by inappropriate antimicrobial use. Antimicrobial stewardship programs (ASPs) improve the use of antimicrobials in hospitals. The purpose of this study is to identify the need for and barriers to implementation of ASPs in three hospitals in Sri Lanka, Kenya, and Tanzania.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2017
CompletedFirst Posted
Study publicly available on registry
December 26, 2017
CompletedStudy Start
First participant enrolled
March 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2019
CompletedJuly 17, 2019
July 1, 2019
12 months
December 19, 2017
July 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Appropriate antimicrobial use, for example for urinary syndromes
A composite outcome will be created for 'inappropriate' antibiotic use. This outcome will consist of 1) Unnecessary treatment for asymptomatic bacteriuria, 2) Inappropriate duration of therapy for urinary tract infection (UTI)/ cystitis/ pyelonephritis (binary outcome- yes/no), and 3) Unnecessary double coverage for UTI/ cystitis/ pyelonephritis (binary outcome- yes/no)
6 months
Interventions
A basic antimicrobial stewardship team will be created at each site. The team will provide advice on the treatment of urinary tract infections and asymptomatic bacteriuria during the second half of the study.
Eligibility Criteria
Patients admitted to the adult medical wards at the three hospitals during the duration of the study will be eligible.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Moi Universitycollaborator
- Kilimanjaro Christian Medical Centre, Tanzaniacollaborator
- Ruhuna University, Sri Lankacollaborator
Study Sites (1)
Teaching Hospital Karapitiya
Galle, Sri Lanka
Study Officials
- PRINCIPAL INVESTIGATOR
Gayani Tillekeratne, MD MSc
Assistant Professor of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2017
First Posted
December 26, 2017
Study Start
March 12, 2018
Primary Completion
March 8, 2019
Study Completion
March 8, 2019
Last Updated
July 17, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share